Protein Complexes and Target Genes Identification by in Vivo Biotinylation: The STAT5 Paradigm

被引：2
|
作者：
Katsantoni, Eleni [1 ]
机构：
[1] Acad Athens, Biomed Res Fdn, Div Hematol Oncol, Athens 11527, Greece
来源：
SCIENCE SIGNALING | 2012年 / 5卷 / 248期
关键词：
FUNCTIONAL INTERACTIONS; NUCLEAR TRANSLOCATION; TRANSCRIPTION FACTOR; ACTIVATION; PHOSPHORYLATION; EXPRESSION; INDUCTION; APOPTOSIS; RECEPTOR; BINDING;
D O I：
10.1126/scisignal.2003622
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Signal transducers and activators of transcription (STATs) are implicated in physiological cellular processes, stress-related responses, and malignancies. This presentation provides an overview on STATs, focusing on STAT5, and describes an in vivo biotinylation methodology applied in mammalian cells for identification of STAT5-containing protein complexes and STAT5 target genes. Our results show that in vivo biotinylation can be used efficiently to elucidate the complex STAT5-dependent transcriptional mechanisms.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] PhosFlow Detection of STAT5 Phosphorylation Following Antigen or Cytokine Administration In Vivo
    Wannberg-Anderson, Sharon L.
    Covey, Todd
    Smelt, Sara C.
    INFLAMMATION RESEARCH, 2005, 54 : S184 - S184
  • [32] Effect of the targeted disruption of STAT4 and STAT5 genes on the induction of experimental autoimmune encephalomyelitis
    Chitnis, T
    Najafian, NN
    Grusby, MJ
    Sayegh, MH
    Khoury, SJ
    NEUROLOGY, 2001, 56 (08) : A466 - A466
  • [33] HIV-1 Nef protein inhibits STAT5 transactivation
    Selliah, N
    DeSimone, D
    Finkel, T
    FASEB JOURNAL, 2003, 17 (07): : C229 - C229
  • [34] Constitutive activation of zebrafish Stat5 expands hematopoietic cell populations in vivo
    Lewis, RS
    Stephenson, SEM
    Ward, AC
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (02) : 179 - 187
  • [35] Nanomolar-Potency Small Molecule Inhibitor of STAT5 Protein
    Cumaraswamy, Abbarna A.
    Lewis, Andrew M.
    Geletu, Mulu
    Todic, Aleksandra
    Diaz, Diego B.
    Cheng, Xin Ran
    Brown, Carla E.
    Laister, Rob C.
    Muench, David
    Kerman, Kagan
    Grimes, H. Leighton
    Minden, Mark D.
    Gunning, Patrick T.
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (11): : 1202 - 1206
  • [36] A nanomolar-potency small molecule inhibitor of the STAT5 protein
    Cumaraswamy, A. A.
    Lewis, A.
    Geletu, M.
    Todic, A.
    Diaz, D. B.
    Cheng, X. R.
    Brown, C. E.
    Laister, R.
    Muench, D.
    Kerman, K.
    Grimes, H. L.
    Minden, M. D.
    Gunning, P. T.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 94 - 94
  • [37] Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation
    Onishi, M
    Nosaka, T
    Misawa, K
    Mui, ALF
    Gorman, D
    McMahon, M
    Miyajima, A
    Kitamura, T
    MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (07) : 3871 - 3879
  • [38] Cutting edge: Identification of an additional isoform of STAT5 expressed in immature macrophages
    Lokuta, MA
    McDowell, MA
    Paulnock, DM
    JOURNAL OF IMMUNOLOGY, 1998, 161 (04): : 1594 - 1597
  • [39] Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer
    Erb, Holger H. H.
    Bodenbender, Julia
    Handle, Florian
    Diehl, Tamara
    Donix, Lukas
    Tsaur, Igor
    Gleave, Martin
    Haferkamp, Axel
    Huber, Johannes
    Fuessel, Susanne
    Juengel, Eva
    Culig, Zoran
    Thomas, Christian
    PLOS ONE, 2020, 15 (08):
  • [40] Energy Metabolism in Cancer: The Roles of STAT3 and STAT5 in the Regulation of Metabolism-Related Genes
    Valle-Mendiola, Arturo
    Soto-Cruz, Isabel
    CANCERS, 2020, 12 (01)
12345